Cargando…
Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
Tumour response to therapy is assessed primarily in the clinic by monitoring reductions in tumour size. However, this approach lacks sensitivity since in many cases several weeks may elapse before there is evidence of tumour shrinkage. There is therefore a need to develop non-invasive imaging techni...
Autores principales: | Witney, Timothy H., Fortt, Robin R., Aboagye, Eric O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950258/ https://www.ncbi.nlm.nih.gov/pubmed/24618809 http://dx.doi.org/10.1371/journal.pone.0091694 |
Ejemplares similares
-
Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
por: Witney, Timothy H., et al.
Publicado: (2020) -
Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
Publicado: (2014) -
Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using (18)F-ICMT-11 and (18)F-FLT PET
por: Heinzmann, Kathrin, et al.
Publicado: (2018) -
Clinical translation of [(18)F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer
por: Dubash, S. R., et al.
Publicado: (2018) -
Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020)